» Articles » PMID: 22752308

The 2009 Prospective Multi-center Epidemiologic Survey of Uveitis in Japan

Overview
Specialty Ophthalmology
Date 2012 Jul 4
PMID 22752308
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate etiologic data on intraocular inflammation in Japan collected in the 2009 epidemiologic survey of uveitis in Japan and assess the current state of etiology compared with that reported in a previous survey.

Methods: Thirty-six university hospitals participated in this prospective etiologic study. Patients who visited the outpatient uveitis clinic of each hospital for the first time between 1 June 2009 and 31 May 2010 were enrolled in the study. Uveitic diseases were diagnosed according to the guidelines when available or following commonly accepted diagnostic criteria.

Results: A total of 3,830 patients were enrolled in the survey and 2,556 cases of uveitis were identified, of which 1,274 cases were described as unclassified intraocular inflammation. In the identified cases, the most frequent intraocular inflammatory disease was sarcoidosis (10.6 %), followed by Vogt-Koyanagi-Harada disease (7.0 %), acute anterior uveitis (6.5 %), scleritis (6.1 %), herpetic iridocyclitis (4.2 %), Behçet's disease (3.9 %), bacterial endophthalmitis (2.5 %), masquerade syndrome (2.5 %), Posner-Schlossman syndrome (1.8 %), and retinal vasculitis (1.6 %).

Conclusions: The current etiology of uveitis in Japan was elucidated by means of a multi-center prospective survey. Conducting such surveys on a periodic basis may help clinicians in their management of uveitis.

Citing Articles

The epidemiology of uveitis: comparison of its causes and visual outcomes between three-tiered medical facilities in Ube city.

Yanai R, Uchi S, Kondo Y, Fujitsu Y, Suzuki K, Yoshimura K Sci Rep. 2025; 15(1):8998.

PMID: 40089526 DOI: 10.1038/s41598-025-93223-x.


Retromode Infrared Scanning Laser Ophthalmoscopy in Vogt-Koyanagi-Harada Disease.

Yasuda S, Yoshida T, Suzuki Y, Sugahara Y, Lee J, Kamoi K Graefes Arch Clin Exp Ophthalmol. 2024; .

PMID: 39585405 DOI: 10.1007/s00417-024-06693-6.


Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.

Feng H, Chen W, Yang J, Kong H, Li H, He Y BMC Ophthalmol. 2024; 24(1):238.

PMID: 38849758 PMC: 11157948. DOI: 10.1186/s12886-024-03511-9.


Diagnostic and therapeutic challenges in acute retinal necrosis; an update.

Kalogeropoulos D, Afshar F, Kalogeropoulos C, Vartholomatos G, Lotery A Eye (Lond). 2024; 38(10):1816-1826.

PMID: 38519714 PMC: 11226642. DOI: 10.1038/s41433-024-03028-x.


Vogt-Koyanagi-Harada disease developed during chemotherapy for Hodgkin lymphoma: a case report.

Koyama M, Nishijima E, Honda T, Gonmori-Ohta C, Sasamoto T, Tanaka K BMC Ophthalmol. 2024; 24(1):115.

PMID: 38481205 PMC: 10935796. DOI: 10.1186/s12886-024-03386-w.


References
1.
Shindo Y, Inoko H, Yamamoto T, Ohno S . HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol. 1994; 78(3):223-6. PMC: 504742. DOI: 10.1136/bjo.78.3.223. View

2.
Sakai J, Usui Y, Sakai M, Yokoi H, Goto H . Clinical statistics of endogenous uveitis: comparison between general eye clinic and university hospital. Int Ophthalmol. 2010; 30(3):297-301. DOI: 10.1007/s10792-009-9336-5. View

3.
Chang J, Wakefield D . Uveitis: a global perspective. Ocul Immunol Inflamm. 2003; 10(4):263-79. DOI: 10.1076/ocii.10.4.263.15592. View

4.
Levinson R, Rajalingam R, Park M, Reed E, Gjertson D, Kappel P . Human leukocyte antigen A29 subtypes associated with birdshot retinochoroidopathy. Am J Ophthalmol. 2004; 138(4):631-4. DOI: 10.1016/j.ajo.2004.06.016. View

5.
Read R, Holland G, RAO N, Tabbara K, Ohno S, Arellanes-Garcia L . Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001; 131(5):647-52. DOI: 10.1016/s0002-9394(01)00925-4. View